Department of Bioscience and Biotechnology, Konkuk University, Seoul 143-701, Republic of Korea.
Appl Microbiol Biotechnol. 2010 Jun;87(1):9-19. doi: 10.1007/s00253-010-2567-6. Epub 2010 Apr 8.
Ginsenosides are the principal components responsible for the pharmaceutical activities of ginseng. The minor ginsenosides, which are also pharmaceutically active, can be produced via the hydrolysis of the sugar moieties in the major ginsenosides using acid hydrolytic, heating, microbial, and enzymatic transformation techniques. The enzymatic method has a profound potential for ginsenoside transformation, owing to its high specificity, yield, and productivity, and this method is increasingly being recognized as a useful tool in structural modification and metabolism studies. In this article, the transformation methods of ginsenosides, the characterization of microbial glycosidases with ginsenoside hydrolyzing activities, and the enzymatic production of minor ginsenosides are reviewed. Moreover, the conversions of ginsenosides using cell extracts from food microorganisms and recombinant thermostable beta-D-glycosidases are proposed as feasible methods for use in industrial processes.
人参皂苷是人参具有药物活性的主要成分。利用酸水解、加热、微生物和酶转化技术,可将主要人参皂苷的糖基部分水解,得到具有药物活性的低含量人参皂苷。酶法由于其高特异性、高收率和高生产力,在人参皂苷转化方面具有巨大的潜力,并且这种方法越来越被认为是结构修饰和代谢研究的有用工具。本文综述了人参皂苷的转化方法、具有人参皂苷水解活性的微生物糖苷酶的特性以及低含量人参皂苷的酶法生产。此外,还提出了利用食品微生物细胞提取物和重组耐热β-D-糖苷酶转化人参皂苷的方法,作为工业应用中可行的方法。